407
Participants
Start Date
August 31, 2001
Primary Completion Date
October 31, 2003
Study Completion Date
October 31, 2003
somatropin
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Lillestrøm
Novo Nordisk Investigational Site, Durban
Novo Nordisk Investigational Site, Worcester
Novo Nordisk Investigational Site, Cape Town
Novo Nordisk Investigational Site, Cape Town
Novo Nordisk Investigational Site, Győr
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Hamburg
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Braunschweig
Novo Nordisk Investigational Site, Kfar Save
Novo Nordisk Investigational Site, Valencia
Novo Nordisk Investigational Site, Münster
Novo Nordisk Investigational Site, Mainz
Novo Nordisk Investigational Site, Offenbach
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Homburg
Novo Nordisk Investigational Site, Ludwigshafen
Novo Nordisk Investigational Site, Strasbourg
Novo Nordisk Investigational Site, Kuopio
Novo Nordisk Investigational Site, München
Novo Nordisk Investigational Site, Beersheba
Novo Nordisk Investigational Site, Augsburg
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Jerusalem
Novo Nordisk Investigational Site, Würzburg
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Miskolc
Novo Nordisk Investigational Site, Veszprém
Novo Nordisk Investigational Site, Oslo
Novo Nordisk Investigational Site, Gorzów
Novo Nordisk Investigational Site, Krakow
Novo Nordisk Investigational Site, Piekary Śląskie
Novo Nordisk Investigational Site, Sosnowiec
Novo Nordisk Investigational Site, Szczecin-Zdunowo
Novo Nordisk Investigational Site, Cape Town
Lead Sponsor
Novo Nordisk A/S
INDUSTRY